Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Alcon Inc. (ACL)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on ACL
Newest on ACL
Bullish Bankers
(1)
The Mole
(1)
SA Editor Rachael Granby
(2)
Market Folly
(3)
EP Vantage
(1)
Most frequent on ACL
Zacks.com
(
3
)
Market Folly
(
3
)
SA Editor Miriam Metzinger
(
3
)
Mike Havrilla
(
2
)
Dividend Growth Investor
(
2
)
Most followed on ACL
Philip Davis
(
2660
)
SA Editor Rachael Granby
(
1322
)
Mike Havrilla
(
1130
)
Market Folly
(
1094
)
Dividends4Life
(
945
)
Most commented on ACL
SA Editor Rachael Granby
(
23
)
Philip Davis
(
8
)
The Mole
(
7
)
Dividend Growth Investor
(
7
)
Dividends4Life
(
4
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Alcon Inc. (ACL)
by
latest
|
most commented
Generic Players Continue to Impress in H1
Jul 2
•
EP Vantage
•
ABBI
,
ALO
,
ACL
•
Comment!
|
Quick Read
Alcon's Growth Stymied by the Economy
Jun 23
•
Zacks.com
•
ACL
•
Comment!
|
Quick Read
The 30 Best U.S. Traded International Dividend Stocks
Jun 14
•
Dividend Growth Investor
•
BHP
,
AZN
,
ACL
•
5 Comments
|
Quick Read
Viking's Q109 Shows Conviction for Mastercard and Visa Duopoly
May 18
•
Market Folly
•
ACE
,
ADS
,
ACL
•
Comment!
|
Quick Read
Eleven Companies Bucking the Dividend Cut Trend
May 11
•
Dividend Growth Investor
•
AVA
,
BBT
,
ACL
•
2 Comments
|
Quick Read
Pepsico and 6 Other 'Dividend Increasers'
May 9
•
Dividends4Life
•
EXPD
,
AVA
,
ACL
•
4 Comments
|
Quick Read
Alcon Pharma: Facing Up to Its Challenges
Apr 24
•
Zacks.com
•
ACL
•
Comment!
|
Quick Read
Outlook on Healthcare Products and Supplies
Apr 6
•
Bullish Bankers
•
BDX
,
ABT
,
ACL
•
1 Comment
|
Quick Read
Farallon Capital's Q408: Betting on MasterCard
Apr 2
•
Market Folly
•
ABT
,
ABI
,
AAPL
•
1 Comment
|
Quick Read
Hedge Fund Portfolio Tracking: Andreas Halvorsen's Viking Global, Q4 2008
Feb 26
•
Market Folly
•
ACE
,
ABFS
,
ACL
•
Comment!
|
Quick Read
Wall Street Breakfast: Must-Know News
Feb 19
•
SA Editor Rachael Granby
•
AAP
,
ADI
,
ACL
•
9 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Feb 12
•
SA Editor Rachael Granby
•
AET
,
ACH
,
ACL
•
14 Comments
|
Quick Read
Preview from Europe: Four Day Winning Streak Snapped
Jan 30
•
The Mole
•
CAJ
,
CRH
,
ACL
•
7 Comments
|
Quick Read
Expanding the Defensive Growth Index Into Europe
Oct 23, 2008
•
Mike Havrilla
•
BTI
,
BAX
,
ACL
•
Comment!
|
Quick Read
Novartis: An Ex-U.S. Proxy for Global Healthcare
Jul 27, 2008
•
Mike Havrilla
•
IXJ
,
JNJ
,
ACL
•
Comment!
|
Quick Read
Alcon Raises Guidance as Stock Soars
Jun 19, 2008
•
Joshua Hayes
•
ACL
•
1 Comment
|
Quick Read
Options Trader: Monday Outlook
Apr 7, 2008
•
Philip Davis
•
NVS
,
MSFT
,
ACL
•
8 Comments
|
Quick Read
Wall Street Breakfast: Must-Know News
Apr 7, 2008
•
SA Editor Eli Hoffmann
•
AMR
,
AIG
,
ACL
•
3 Comments
|
Quick Read
Alcon Currently at Fair Value
Apr 1, 2008
•
Zacks.com
•
ACL
•
Comment!
|
Quick Read
Partial Spinoffs: The Progeny Beat the Parents
Feb 25, 2008
•
Stephen Rosenman
•
CY
,
EMC
,
ACL
•
3 Comments
|
Quick Read
Goldman: Higher Bid for Bausch & Lomb Unlikely; Johnson & Johnson, Alcon Rally
May 16, 2007
•
FP Trading Desk
•
JNJ
,
BOL
,
ACL
•
Comment!
|
Quick Read
Alcon: An Eye to the Future
Dec 10, 2006
•
SA Editor Eli Hoffmann
•
ACL
•
Comment!
|
Quick Read
Who Gains, Who Loses From the Bausch & Lomb Recall? (BOL, JNJ, COO, ACL, AGN, EYE, CTAC)
Apr 11, 2006
•
Jon Ogg
•
AGN
,
BOL
,
ACL
•
Comment!
|
Quick Read